T. Rowe Price Investment Management, Inc. Immunocore Holdings PLC Transaction History
T. Rowe Price Investment Management, Inc.
- $151 Billion
- Q1 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 7,051,818 shares of IMCR stock, worth $226 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,051,818
Previous 6,700,208
5.25%
Holding current value
$226 Million
Previous $198 Million
5.85%
% of portfolio
0.14%
Previous 0.12%
Shares
6 transactions
Others Institutions Holding IMCR
# of Institutions
133Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
Wellington Management Group LLP Boston, MA6.13MShares$197 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$156 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$86 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$74.6 Million0.82% of portfolio
-
Tang Capital Management LLC San Diego, CA1.92MShares$61.5 Million3.69% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.41B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...